GGrantIndex
Sort

261,768 grants matching gene therapy

Brain Imaging, APOE & the Preclinical Course of Alzheimer's Disease

$2,054,622
Eric M Reiman · Banner Alzheimer'S Institute · R01 · FY2018 · AG

Longevity and Stress Resistance

$2,054,477
Stephen F Vatner · Univ Of Med/Dent Of Nj-Nj Medical School · P01 · FY2010 · AG

Immuno-Prophylaxis-Therapy & Diagnosis of Tularemia

$2,054,378
John R. Murphy · Boston Medical Center · U19 · FY2007 · AI

Functional Polymorphism Analysis in Drug Pathways

$2,054,116
Washington University · U01 · FY2002 · GM

Genetic characterization of atypical parkinsonism

$2,053,866
Sonja Scholz · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS

Computational Pathology Research for Cancer Modeling, Diagnostics and Biomarkers

$2,053,644
Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA

Prevention of AIDS

$2,053,144
Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Gene Therapy Platform for Rare Diseases

$2,053,144
Na Yang · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR

FUNCTIONAL GENOMICS OF THE BETA-CELL

$2,052,934
University Of Pennsylvania · U01 · FY2005 · DK

Center of Biomedical Research Excellence in Molecular *

$2,052,871
Donald M Miller · University Of Louisville · P20 · FY2006 · RR

Immunologic Approaches to Ovarian Cancer

$2,052,807
David R Spriggs · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA

Antecedent Biomarkers For AD: The Adult Children Study

$2,052,600
John Morris · Washington University · P01 · FY2019 · AG

Papillomavirus Virion Proteins and Vaccines

$2,052,333
John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Development of Novel Therapeutic Strategies in Human Leukemias

$2,052,164
Benjamin Levine Ebert · Dana-Farber Cancer Inst · P01 · FY2025 · CA

Mechanisms of Down syndrome-associated swallowing dysfunction in mouse models

$2,051,875
Nadine Pattakos Connor · University Of Wisconsin-Madison · R01 · FY2022 · DC

Diverse Strategies to Correct the Dystrophin Gene Using Vascular Delivery (U54)

$2,051,556
Jerry Mendell · Research Inst Nationwide Children'S Hosp · U54 · FY2008 · NS

SPORE in Brain Cancer

$2,051,421
Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA

SPORE in Brain Cancer

$2,051,421
Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA

SPORE in Brain Cancer

$2,051,421
Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA

Targeting Pten - An Upstream, Downstream and Offstream Approach

$2,051,414
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2013 · CA

Comprehensive Sickle Cell Center

$2,051,280
St. Jude Children'S Research Hospital · U54 · FY2005 · HL

Silica Nanocapsule-Mediated Nonviral Delivery of CRISPR Base Editor mRNA and Allele Specific sgRNA for Gene Correction in Leber Congenital Amaurosis

$2,051,273
Shaoqin - Gong · University Of Wisconsin-Madison · U19 · FY2024 · NS

Molecular Analysis Of Leukocyte Activation By Chemoattractants

$2,051,146
Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

Costimulatory Mechanisms of Autoimmunity (Composite)

$2,050,980
David A. Hafler · Yale University · P01 · FY2013 · AI

Leber's Hereditary Optic Neuropathy: Gene Therapy Clinical Trial

$2,050,445
John R Guy · University Of Miami School Of Medicine · U10 · FY2015 · EY